Morgan Stanley (MS) is down 6.5% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears driven more by a broader risk-off selloff in large financials than by a fresh Morgan Stanley-specific announcement. Recent market anxiety about AI-related economic disruption has contributed to abrupt rotations away from cyclical sectors like banks, and MS has been volatile alongside peers.
Details:
Sources:
GuruFocus, Investor's Business Daily, MarketWatch
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$MS Insider Trading Activity
$MS insiders have traded $MS stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $MS stock by insiders over the last 6 months:
- EDWARD PICK (Chairman and CEO) sold 100,000 shares for an estimated $16,434,440
- DANIEL A SIMKOWITZ (Co-President) sold 32,968 shares for an estimated $6,020,312
- ANDREW M SAPERSTEIN (Co-President) has made 0 purchases and 6 sales selling 30,330 shares for an estimated $5,569,085.
- ERIC F GROSSMAN (Chief Legal/Admin Officer) sold 21,555 shares for an estimated $3,966,137
- MICHAEL A. PIZZI (Head Technology & Operations) sold 20,000 shares for an estimated $3,691,000
- SHARON YESHAYA (Chief Financial Officer) sold 15,838 shares for an estimated $2,942,176
- CHARLES A SMITH (Chief Risk Officer) sold 8,500 shares for an estimated $1,547,685
- MANDELL CRAWLEY (Chief Client Officer) has made 0 purchases and 5 sales selling 7,860 shares for an estimated $1,441,879.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MS Hedge Fund Activity
We have seen 1,201 institutional investors add shares of $MS stock to their portfolio, and 1,011 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 27,181,077 shares (-74.8%) from their portfolio in Q4 2025, for an estimated $4,825,456,599
- CAPITAL INTERNATIONAL INVESTORS removed 6,777,117 shares (-24.8%) from their portfolio in Q4 2025, for an estimated $1,203,141,581
- CAPITAL WORLD INVESTORS removed 5,048,925 shares (-89.2%) from their portfolio in Q4 2025, for an estimated $896,335,655
- CAPITAL RESEARCH GLOBAL INVESTORS removed 3,816,598 shares (-19.8%) from their portfolio in Q4 2025, for an estimated $677,560,642
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,364,080 shares (+29.1%) to their portfolio in Q4 2025, for an estimated $597,225,122
- WELLINGTON MANAGEMENT GROUP LLP removed 2,880,247 shares (-15.4%) from their portfolio in Q4 2025, for an estimated $511,330,249
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 2,436,717 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $387,340,534
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MS Congressional Stock Trading
Members of Congress have traded $MS stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $MS stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE STEVE COHEN sold up to $100,000 on 12/17.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 09/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$MS Analyst Ratings
Wall Street analysts have issued reports on $MS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/05/2026
- Wolfe Research issued a "Outperform" rating on 11/24/2025
- Jefferies issued a "Buy" rating on 10/16/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 10/16/2025
- Evercore ISI Group issued a "Outperform" rating on 10/16/2025
- BMO Capital issued a "Outperform" rating on 10/03/2025
To track analyst ratings and price targets for $MS, check out Quiver Quantitative's $MS forecast page.
$MS Price Targets
Multiple analysts have issued price targets for $MS recently. We have seen 10 analysts offer price targets for $MS in the last 6 months, with a median target of $176.0.
Here are some recent targets:
- Christopher McGratty from Keefe, Bruyette & Woods set a target price of $210.0 on 01/16/2026
- Kian Abouhossein from JP Morgan set a target price of $162.0 on 01/08/2026
- Jason Goldberg from Barclays set a target price of $219.0 on 01/05/2026
- Glenn Schorr from Evercore ISI Group set a target price of $175.0 on 10/16/2025
- Mike Mayo from Wells Fargo set a target price of $177.0 on 10/16/2025
- Daniel Fannon from Jefferies set a target price of $186.0 on 10/16/2025
- Keith Horowitz from Citigroup set a target price of $170.0 on 10/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.